Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/13/24
End: 03/13/27
Due: 03/13/28
Phase: N/A
Priority: Normal
Start: 05/28/25
End: 12/30/27
Due: 12/30/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases | NCT06318533 | YANRU WANG | user2@example.com | None | 2024-03-13 | 2027-03-13 | 2028-03-13 | - | - | 2025-07-14 |
| A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors | NCT06976437 | YANRU WANG | user2@example.com | None | 2025-05-28 | 2027-12-30 | 2028-12-30 | - | - | 2025-07-14 |